112 related articles for article (PubMed ID: 886741)
1. [Changes of the thrombagglutination test in coronary disease after treatment with heparin].
Atanasov K; Iovkova T
Kardiologiia; 1977 May; 17(5):142-3. PubMed ID: 886741
[No Abstract] [Full Text] [Related]
2. [Antithrombotic therapy of ischemic heart disease].
Liusov VA; Belousov IuB
Kardiologiia; 1974 Jul; 14(7):113-21. PubMed ID: 4431131
[No Abstract] [Full Text] [Related]
3. Heparin coupled to albumin, dextran and ficoll: influence on blood coagulation and platelets, and in vivo duration.
Teien AN; Odegård R; Christensen TB
Thromb Res; 1975 Aug; 7(2):273-84. PubMed ID: 1162648
[No Abstract] [Full Text] [Related]
4. [Coagulation studies and treatment with heparin in a case of hemolytic-uremic-syndrome (author's transl)].
Ploier R
Padiatr Padol; 1974; 9(3):276-81. PubMed ID: 4408956
[No Abstract] [Full Text] [Related]
5. [Interaction of heparin and thrombocytes (a review of the Soviet and foreign literature)].
Traskunova NV; Rokhmistrova VD
Vestn Khir Im I I Grek; 1980 Apr; 124(4):142-6. PubMed ID: 6992400
[No Abstract] [Full Text] [Related]
6. [Effect of exogenous heparin on heparinemia and coagulation in coronary arteriosclerosis].
Szigeti I; Kótay-Lákatos E; Vertán MZ; Kiss R
Med Interna (Bucur); 1967 May; 19(5):549-52. PubMed ID: 6077944
[No Abstract] [Full Text] [Related]
7. [The use of heparin and fibrinolysin in patients with coronary arteriosclerosis].
Aleĭnikova LI
Vrach Delo; 1966 Mar; 3():53-6. PubMed ID: 4230197
[No Abstract] [Full Text] [Related]
8. [The effect of finoptin on platelet aggregation, blood coagulability and fibrinolysis in patients with ischemic heart disease during physical exercise].
Kovalenko VM; Shunkova EI; Gol'dberg GA; Karagaeva LG; Shlafer ID; Epifantseva NN
Kardiologiia; 1991 Sep; 31(9):42-4. PubMed ID: 1753613
[TBL] [Abstract][Full Text] [Related]
9. [Effect of heparin on the aggregation function of thrombocytes].
Zhukovskaia ES; Blindar' VN
Farmakol Toksikol; 1984; 47(5):36-40. PubMed ID: 6500033
[TBL] [Abstract][Full Text] [Related]
10. Molecular weight of heparin versus biologic activity. Some additional considerations.
Losito R; Losito C
Semin Thromb Hemost; 1985 Jan; 11(1):29-33. PubMed ID: 2579437
[No Abstract] [Full Text] [Related]
11. Influence of aspirin or heparin on platelet function and postoperative blood loss after coronary artery bypass surgery.
Sirvinskas E; Veikutiene A; Grybauskas P; Cimbolaityte J; Mongirdiene A; Veikutis V; Raliene L
Perfusion; 2006 Jan; 21(1):61-6. PubMed ID: 16485701
[TBL] [Abstract][Full Text] [Related]
12. Platelet involvement in the activated coagulation time of heparinized blood.
Moorehead MT; Westengard JC; Bull BS
Anesth Analg; 1984 Apr; 63(4):394-8. PubMed ID: 6367544
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulants in heart disease.
Vine DL
Kans Med; 1991 Apr; 92(4):114, 112. PubMed ID: 1881021
[No Abstract] [Full Text] [Related]
14. [Medical treatment of the intermediate coronary syndrome with heparin].
Ruggiero HA; Previde O; Califano JE; Bare G; Luzzi R; Beilis P
Rev Clin Esp; 1978 Oct; 151(1):19-22. PubMed ID: 740966
[No Abstract] [Full Text] [Related]
15. [Current problems of antithrombotic therapy].
Liusov VA; Belousov IuB
Kardiologiia; 1981 Aug; 21(8):5-17. PubMed ID: 7026869
[No Abstract] [Full Text] [Related]
16. [Heparin therapy].
Kirichenko LL
Kardiologiia; 1987 Jul; 27(7):119-23. PubMed ID: 3656912
[No Abstract] [Full Text] [Related]
17. Heparin, heparin fractions, and the atherosclerotic process.
Engelberg H
Semin Thromb Hemost; 1985 Jan; 11(1):48-55. PubMed ID: 3883499
[No Abstract] [Full Text] [Related]
18. [Blood coagulation--pharmacotherapeutic modification].
Schlick E
Med Monatsschr Pharm; 1982 Jan; 5(1):1-10. PubMed ID: 7057733
[No Abstract] [Full Text] [Related]
19. [Effect of unsaturated fatty acids on the state of the blood coagulation and anticoagulation system in patients with coronary arteriosclerosis].
Bobkova VI; Ezhova IS
Kardiologiia; 1970 Oct; 10(10):26-30. PubMed ID: 5504112
[No Abstract] [Full Text] [Related]
20. Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab.
Furman MI; Kereiakes DJ; Krueger LA; Mueller MN; Pieper K; Broderick TM; Schneider JF; Howard WL; Fox ML; Barnard MR; Frelinger AL; Michelson AD
Am Heart J; 2001 Nov; 142(5):790-8. PubMed ID: 11685164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
